Fenghui Zhao

1.1k total citations
18 papers, 442 citations indexed

About

Fenghui Zhao is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fenghui Zhao has authored 18 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fenghui Zhao's work include Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (7 papers) and Diabetes Treatment and Management (6 papers). Fenghui Zhao is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (7 papers) and Diabetes Treatment and Management (6 papers). Fenghui Zhao collaborates with scholars based in China, Japan and Australia. Fenghui Zhao's co-authors include Qinglian Hu, Zhengwei Fu, Dehua Yang, Ming‐Wei Wang, Qingtong Zhou, Shuhong Han, H. Eric Xu, Zhaotong Cong, Lihua Zhao and Wenbo Feng and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Fenghui Zhao

17 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fenghui Zhao China 13 226 109 109 81 65 18 442
Yevgeniya Lukyanenko United States 14 298 1.3× 65 0.6× 36 0.3× 36 0.4× 38 0.6× 25 573
Yanfei Han China 13 222 1.0× 67 0.6× 49 0.4× 61 0.8× 9 0.1× 27 673
Xiaobing Du China 11 334 1.5× 102 0.9× 33 0.3× 31 0.4× 44 0.7× 24 649
Xudong Feng United States 10 139 0.6× 48 0.4× 93 0.9× 14 0.2× 10 0.2× 11 421
Michael McHugh Canada 8 112 0.5× 54 0.5× 79 0.7× 46 0.6× 13 0.2× 11 397
Olesia Buiakova United States 9 116 0.5× 174 1.6× 37 0.3× 27 0.3× 13 0.2× 14 579
Alexis Lebon France 10 165 0.7× 162 1.5× 16 0.1× 27 0.3× 38 0.6× 22 416
Sihem Aouabdi Saudi Arabia 8 233 1.0× 92 0.8× 15 0.1× 87 1.1× 25 0.4× 15 449
Nicholas H. F. Fine United Kingdom 12 220 1.0× 93 0.9× 77 0.7× 13 0.2× 107 1.6× 16 520

Countries citing papers authored by Fenghui Zhao

Since Specialization
Citations

This map shows the geographic impact of Fenghui Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenghui Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenghui Zhao more than expected).

Fields of papers citing papers by Fenghui Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenghui Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenghui Zhao. The network helps show where Fenghui Zhao may publish in the future.

Co-authorship network of co-authors of Fenghui Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Fenghui Zhao. A scholar is included among the top collaborators of Fenghui Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenghui Zhao. Fenghui Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cao, Yinglong, Chao Zhang, Qingning Yuan, et al.. (2025). Mechanisms of chemokine recognition and receptor activation of chemokine receptor CCR7. Cell Reports. 44(11). 116582–116582.
2.
Zhou, Qingtong, Fenghui Zhao, Yao Zhang, Dehua Yang, & Ming‐Wei Wang. (2025). Structural pharmacology and mechanisms of GLP-1R signaling. Trends in Pharmacological Sciences. 46(5). 422–436. 4 indexed citations
3.
Cong, Zhaotong, Fenghui Zhao, Yang Li, et al.. (2024). Molecular features of the ligand-free GLP-1R, GCGR and GIPR in complex with Gs proteins. Cell Discovery. 10(1). 18–18. 14 indexed citations
4.
Chen, Yan, Qingtong Zhou, Jiang Wang, et al.. (2023). Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4). Nature Communications. 14(1). 492–492. 7 indexed citations
5.
Duan, Jia, Heng Liu, Fenghui Zhao, et al.. (2023). GPCR activation and GRK2 assembly by a biased intracellular agonist. Nature. 620(7974). 676–681. 58 indexed citations
6.
Feng, Wenbo, Qingtong Zhou, Antao Dai, et al.. (2023). Structural insights into ligand recognition and subtype selectivity of the human melanocortin-3 and melanocortin-5 receptors. Cell Discovery. 9(1). 81–81. 16 indexed citations
7.
Li, Yang, Qingtong Zhou, Antao Dai, et al.. (2023). Structural analysis of the dual agonism at GLP-1R and GCGR. Proceedings of the National Academy of Sciences. 120(33). e2303696120–e2303696120. 20 indexed citations
8.
Zhao, Fenghui, Qingtong Zhou, Lijun Shao, et al.. (2023). Molecular basis of signal transduction mediated by the human GIPR splice variants. Proceedings of the National Academy of Sciences. 120(41). e2306145120–e2306145120. 2 indexed citations
9.
Feng, Wenbo, Qingtong Zhou, Jie Li, et al.. (2022). A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2. Nature Communications. 13(1). 2272–2272. 16 indexed citations
10.
Cong, Zhaotong, Yi-Lynn Liang, Qingtong Zhou, et al.. (2022). Structural perspective of class B1 GPCR signaling. Trends in Pharmacological Sciences. 43(4). 321–334. 49 indexed citations
11.
Zhao, Fenghui, Chao Zhang, Qingtong Zhou, et al.. (2021). Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor. eLife. 10. 30 indexed citations
12.
Yuliantie, Elita, Wijnand J. C. van der Velden, Antao Dai, et al.. (2021). Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor. Biochemical Pharmacology. 192. 114715–114715. 9 indexed citations
13.
Hu, Qinglian, et al.. (2019). The influence of titanium dioxide nanoparticles on their cellular response to macrophage cells. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 223. 42–52. 19 indexed citations
14.
Zhao, Fenghui, et al.. (2018). Titanium dioxide nanoparticle stimulating pro-inflammatory responses in vitro and in vivo for inhibited cancer metastasis. Life Sciences. 202. 44–51. 22 indexed citations
15.
Han, Shuhong, et al.. (2018). Developmental neurotoxicity and immunotoxicity induced by graphene oxide in zebrafish embryos. Environmental Toxicology. 34(4). 415–423. 56 indexed citations
16.
Hu, Qinglian, et al.. (2017). Cardiovascular toxicity assessment of poly (ethylene imine)- based cationic polymers on zebrafish model. Journal of Biomaterials Science Polymer Edition. 28(8). 768–780. 19 indexed citations
17.
Hu, Qinglian, et al.. (2017). Effects of titanium dioxide nanoparticles exposure on parkinsonism in zebrafish larvae and PC12. Chemosphere. 173. 373–379. 70 indexed citations
18.
Hu, Qinglian, et al.. (2017). Polymeric Nanoparticles Induce NLRP3 Inflammasome Activation and Promote Breast Cancer Metastasis. Macromolecular Bioscience. 17(12). 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026